Anticholinergic Burden in Individuals with Down Syndrome: An Examination of Risk and Clinical Implications
Journal of Personalized Medicine · 26.07.2026 · 16 (8) · 398
DOI: 10.3390/jpm16080398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 26.07.2026. Verfasst von Emanuele Rocco Villani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento dell' Integrazione, Unità Operativa Complessa Geriatria Territoriale, Azienda Unità Sanitaria Locale Modena, 41122 Modena, Italy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/objective: Down syndrome (DS) is characterized by premature aging, with comorbidities observed in the older population without DS, a high prevalence of multimorbidity and cognitive decline. The use of multiple medications further increases clinical complexity. The objective of this paper is to evaluate anticholinergic use and the anticholinergic burden (ACB) in a sample of persons with DS. Methods: cross-sectional retrospective study involving community-dwelling persons with DS, afferent to the DS clinics of the Fondazione Policlinico Universitario “A. Gemelli” (Rome, Italy). Individuals were assessed through a standardized clinical protocol. ACB was evaluated according to the anticholinergic cognitive burden scale, with a score ≥ 3 indicating high risk of anticholinergic side effects. Results: 337 individuals were taking ≥ 1 chronic medication, mean age was 37.7 (±14.6), 158 (43.8%) were females. 143 (39.6%) individuals took ≥ 1 medication with known anticholinergic burden, 51 (14.1%) individuals showed high risk ACB score. High risk ACB score prevalence increased with age (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento dell' Integrazione, Unità Operativa Complessa Geriatria Territoriale, Azienda Unità Sanitaria Locale Modena, 41122 Modena, Italy.
- Department of Geriatric, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Department of Geriatric, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico, 00168 Rome, Italy.
- Clinical Experimental Medicine, Università degli Studi di Modena e Reggio Emilia, 41122 Modena, Italy.
- Dipartimento di Emergenza-Urgenza, Azienda Ospedaliero-Universitaria, 41125 Modena, Italy.
- Scuola di Specializzazione in Pediatria, Alma Mater Studiorum-Università di Bologna, 40126 Bologna, Italy.
ORCID-Profile: Laura Franza, Graziano Onder, Angelo Carfì
Zitieren
APA
Villani, E. R., Liperoti, R., Franza, L., Secciani, F. M., Di Paola, A., Onder, G., & Carfì, A. (2026). Anticholinergic Burden in Individuals with Down Syndrome: An Examination of Risk and Clinical Implications. Journal of Personalized Medicine, 16(8), 398. https://doi.org/10.3390/jpm16080398
Vancouver
Villani ER, Liperoti R, Franza L, Secciani FM, Di Paola A, Onder G, et al. Anticholinergic Burden in Individuals with Down Syndrome: An Examination of Risk and Clinical Implications. Journal of Personalized Medicine. 2026;16(8):398. doi:10.3390/jpm16080398
BibTeX
@article{Villani2026,
author = {Villani, Emanuele Rocco and Liperoti, Rosa and Franza, Laura and Secciani, Francesca Maria and Di Paola, Antonella and Onder, Graziano and Carfì, Angelo},
title = {Anticholinergic Burden in Individuals with Down Syndrome: An Examination of Risk and Clinical Implications},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {8},
pages = {398},
doi = {10.3390/jpm16080398}
}
EUVIMED